12,091 Views
•
09:38 min
•
September 12, 2016
DOI:
Transkrypcja
Automatically generated
Podsumowanie
Automatically generated
This protocol describes how to determine whether pharmacological treatments for experimental autoimmune encephalomyelitis show CNS protection as a consequence of suppressing immune cell infiltration or are neuroprotective during the onslaught of immune cell infiltration.
Powiązane Filmy
08:38
Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge
Powiązane Filmy
20211 Views
09:24
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
Powiązane Filmy
17579 Views
08:47
Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Powiązane Filmy
23512 Views
09:00
Analysis of Lymphocyte Extravasation Using an In Vitro Model of the Human Blood-brain Barrier
Powiązane Filmy
20317 Views
10:50
Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Powiązane Filmy
7594 Views
09:01
Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
Powiązane Filmy
6976 Views
05:55
Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
Powiązane Filmy
729 Views
08:17
Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis
Powiązane Filmy
3808 Views
08:57
In Vitro Myelination of Peripheral Axons in a Coculture of Rat Dorsal Root Ganglion Explants and Schwann Cells
Powiązane Filmy
1956 Views
08:49
Simultaneous Isolation of Principal Central Nervous System-Resident Cell Types from Adult Autoimmune Encephalomyelitis Mice
Powiązane Filmy
1552 Views
Read Article
Cytuj ten artykuł
Evonuk, K. S., Moseley, C. E., Doyle, R. E., Weaver, C. T., DeSilva, T. M. Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination. J. Vis. Exp. (115), e54348, doi:10.3791/54348 (2016).
Copy